Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00368732 · ClinicalTrials.gov registry record
Genetic and Nutritional Causes of Heart Birth Defects
A clinical trial of Heart Defects, Congenital, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 1,610
- Enrollment target
- 1
- Study location
NCT00368732: Completed study of Heart Defects, Congenital, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00368732 is a study of Heart Defects, Congenital that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 1,610 participants, above the 185-participant average among 9 other Heart Defects, Congenital trials with a reported enrollment target (770% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00368732, a study of Heart Defects, Congenital, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 1,610 participants
- Enrollment target
- 1
- Study location
Study Summary
Each year in the United States, thousands of babies are born with heart defects. Women who take folic acid during pregnancy have a lower risk of giving birth to infants with heart defects, but the reason for this remains unknown. This study will examine the relationship between genes, nutrition, and the occurrence of heart defects in infants.
Conditions Studied
Study Locations (1)
California
- California Birth Defects Monitoring Program - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,610 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-12 |
What the finished NCT00368732 record still lists
NCT00368732 is an observational study that tracks outcomes without assigning an intervention. Its 1,610 participants enrollment target places it among the larger protocols in the corpus, above the 185-participant average among 9 other Heart Defects, Congenital trials with a reported enrollment target (770% higher).
The record links to 1 condition, with Heart Defects, Congenital appearing as the primary indexed condition, and to 0 interventions.
NCT00368732 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00368732 about?
NCT00368732 is a clinical study titled "Genetic and Nutritional Causes of Heart Birth Defects". Each year in the United States, thousands of babies are born with heart defects. Women who take folic acid during pregnancy have a lower risk of giving birth to infants with heart defects, but the reason for this remains unknown. This study will examine the relationship between genes, nutrition, and...
What is the current status of trial NCT00368732?
This trial is currently completed. The enrollment target is 1,610 participants. The study started on 2006-07. Estimated completion is 2006-12.
What conditions does trial NCT00368732 study?
This clinical trial studies the following conditions: Heart Defects, Congenital.
Who is sponsoring clinical trial NCT00368732?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00368732 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Defects, Congenital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00368732's enrollment target sits among peer trials
1,610 1st of 9 higher than 9 of 9 other Heart Defects, Congenital trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Defects, Congenital trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
-
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
RECRUITING · Phase 2
-
Congenital Heart Disease Physical Activity Lifestyle Study V.2
RECRUITING · NA
-
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
ACTIVE NOT RECRUITING · NA
-
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
ACTIVE NOT RECRUITING · NA
-
Comparison of Hematocrit Levels in Infant Heart Surgery
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06271590 · 1,605 participants · NA
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- NCT06959524 · 1,616 participants · NA
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia